KLRG1 and neoplasm: In MethA tumor-bearing mice, metformin treatment decreased tumor-infiltrated Treg cells, especially terminally differentiated CD103+ KLRG-1+ Treg cells (active effector Treg cells) accompanied with a decrease in the inhibitory molecules expressed on them.